Today in this blog we will try to know ERIS Lifesciences Share Price Target 2025, 2026, 2027, To 2030 In this blog we are going to analyze the stock ERIS Lifesciences Ltd of the Pharmaceuticals sector. In this blog we will do all the research of the company for you like what does the company do? How can the performance of the company be for 5 years? Future status of the company? You will find information about all this research in this blog.
After reading this blog, you will also get to know about the technical analysis along with fundamentals about ERIS Lifesciences Ltd. From which you can find out whether you should invest in this company or not, so let’s try to know the company.
About ERIS Lifesciences Ltd
Eris Lifesciences Ltd. is an Indian pharmaceutical company that mainly manufactures and sells medicines for chronic diseases. The company has earned a lot of name in the field of treatment of chronic diseases in India.
Eris Lifesciences primarily manufactures medicines for chronic diseases such as diabetes, heart disease, pain, and gynecology. Eris Lifesciences was founded in 2007 and is headquartered in New Delhi, India.
| Company Name | ERIS Lifesciences Ltd |
| Market Cap | ₹ 18,422 Cr. |
| P/E | 56.0 |
| ROE (Return on equity) | 16.3 % |
| ROCE (Return on Capital Employed ) | 11.3 % |
| 52 Week High (11-Dec-2024) | ₹ 1,593.90 |
| 52 Week Low (13-Mar-2024) | ₹ 809.15 |
| DIV. YIELD | 0.00 % |
| Date of Listing | 29-Jun-2017 |
ERIS Lifesciences last 5 Year Performance
If we talk about the returns of ERIS Lifesciences Ltd (ERIS) share in the last few years, then the company has given 52.59% returns to its investors in the last 1 year (Feb 2024 – Feb 2025). And if we talk about 5 Year’s Returns, then it has given 162.85% returns to its investors.
| 3 Month Returns | 2.98% |
| 1 Year’s Returns | 52.59% |
| 5 Year’s Returns | 162.85% |
| Sales growth 3 Years | 18.4 % |
| Sales growth 5 Years | 15.4 % |
| Return over 3years | 19.8 % |
| Return over 5years | 19.1 % |
Read this also:- NLC India Share Price Target 2025, 2026, 2027, To 2030 – Stock Era
ERIS Lifesciences Share Price Target 2025-2030
| Year | Target 1 | Target 2 |
| 2025 | ₹1400 | ₹1500 |
| 2026 | ₹1500 | ₹1600 |
| 2027 | ₹1700 | ₹1900 |
| 2028 | ₹1900 | ₹2200 |
| 2029 | ₹2200 | ₹2500 |
| 2030 | ₹2500 | ₹2900 |
ERIS Lifesciences Share Price Target 2025
Talking about the ERIS Lifesciences Share Price Target 2025, our analysis has said that this stock can remain between ₹ 1400 and ₹ 1500 in 2025.
These targets are given after looking at the data of the past history of the stock. In this, fundamental analysis has been done along with technical analysis.
| Target 1 | Target 2 |
| ₹ 1400 | ₹ 1500 |
ERIS Lifesciences Share Price Target 2026
If the demand in this industry and the sales of this company see an increase, then as per our research the share price of ERIS Lifesciences Ltd may remain between ₹ 1500 and ₹ 1600 by 2026.
| Target 1 | Target 2 |
| ₹ 1500 | ₹ 1600 |
Read this also:- Castrol India Share Price Target 2025, 2026, 2027, To 2030 – Stock Era
ERIS Lifesciences Share Price Target 2027
These share targets have been derived by looking at the company’s past performance. If the company’s performance remains good, then according to our analysts, the target for ERIS Lifesciences shares in 2027 can be between ₹ 1700 and ₹ 1900.
| Target 1 | Target 2 |
| ₹ 1700 | ₹ 1900 |
ERIS Lifesciences Share Price Target 2028
By analyzing the trend and stock of the last few years, it is known that if we talk about the target of ERIS Lifesciences share price in 2028, then it can be between ₹ 1900 and ₹ 2200.
| Target 1 | Target 2 |
| ₹ 1900 | ₹ 2200 |
ERIS Lifesciences Share Price Target 2029
Looking at the history of the last 5 years and the fundamental analysis of the stock, it seems that in the coming years i.e. if we talk about the target of ERIS Lifesciences Share in 2029, then ₹ 2200 and ₹2500 can be seen.
| Target 1 | Target 2 |
| ₹ 2200 | ₹ 2500 |
ERIS Lifesciences Share Price Target 2030
The price of ERIS Lifesciences stock can remain between ₹ 2500 to ₹ 2900 by 2030. This price can also go up or down, this price is told by analyzing the stock data of the last 5 years.
The price of the company’s stock depends on how the company performs in the coming time. You must take the help of your financial advisor before investing.
| Target 1 | Target 2 |
| ₹ 2500 | ₹ 2900 |
ERIS Lifesciences Promoters Holding
Friends, before investing in any company, it is very important to see the holding of the company’s promoters because from this we get an idea that if the promoters of the company have maintained their holding and are not selling it, then the company is performing well and can perform well.
It is said that it is not good if promoter’s holding is less in any company but it is said that if the holdings of FIIs and DIIs are increasing then it is good.
If we talk about the promoters’ holding in this company, it is 54.86% You will see below who else has a stake in it.
| Mar 2022 | Mar 2023 | Mar 2024 | Dec 2024 | |
| Promoters | 52.66% | 52.86% | 54.90% | 54.86% |
| FIIs | 13.31% | 14.86% | 14.27% | 8.36% |
| DIIs | 10.50% | 10.02% | 15.63% | 18.07% |
| Public | 23.52% | 22.27% | 15.20% | 18.73% |
ERIS Lifesciences Peer Companies
- Torrent Pharma.
- Ajanta Pharma
- Gland Pharma
- ERIS Lifescience
- Caplin Point Lab
- Sai Life
- Marksans Pharma
Conclusion
We hope that you have got all the information about ERIS Lifesciences Share Price Target 2025, 2026, 2027, To 2030 properly and how did you like our blog, please tell us by commenting and also tell us what are your thoughts about ERIS Lifesciences Ltd. Do share this article with your friends.
Frequently Asked Questions FAQ’S
How much debt does ERIS Lifesciences have?
As of today when we are posting this blog, ERIS Lifesciences has a debt of ₹ 2,735 Cr.
What does ERIS Lifesciences Ltd do?
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.
Read this also:- Motilal Oswal Share Price Target 2025, 2026, 2027, To 2030 – Stock Era
Disclaimer : The information presented in this article is for educational and informational purposes only. We do not recommend buying or selling stocks. These predictions are based on our research and technical data, any uncertainty in the market may affect the stock price, so investors should do their own research before making investment decisions. We will not be responsible for any loss or damage caused by the use of this article.